Tonix Pharmaceuticals Holding Corp (NAS:TNXP)
$ 0.13795 -0.00325 (-2.3%) Market Cap: 19.31 Mil Enterprise Value: 25.02 Mil PE Ratio: 0 PB Ratio: 0.03 GF Score: 30/100

Tonix Pharmaceuticals Holding Corp to Host KOL Webinar Transcript

Jan 31, 2024 / 06:00PM GMT
Release Date Price: $10.24 (+1.62%)
Unidentified Participant

Because chemo fireside chat on TNX-102 SL ton-mile for the treatment of fibromyalgia, which recently won the FDA conditional approval for the name of Tom Meyer. Please note the appropriate disclosures of photonics that are currently on your screen.

Now, the format of today's panel will be a 60 minute fireside chat with our two guest KOLs, Dr. Leslie Arnold, with the diversity of Cincinnati College of Medicine. And Dr. Dan Clark for the national champion resubmission, kind of pertain of pain and fatigue center also joined us from tonic pharmaceuticals. What we see there to supplement and Chief Medical Officer, Dr. Greg Sullivan, to round out our PAM, our webinar attendees will be muted during the panel. But if anyone has a question, they would like to ask, please feel free to utilize the ask-a-question function on your webinar page or feel free to e-mail me and my e-mail address shown behind me, and I'll turn to get the question as time allows.

I would that I will start with introducing our KOLs today. Please feel free to give us a little background on yourself. Your

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot